The Global Biologics Market is expected to grow from USD 236,057.71 Million in 2019 to USD 304,866.47 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.35%

by NASDAQ Market News July 6, 2020

NASDAQ Market News
Click here to email author

Novartis receives EC approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU

To Fully Focus on Cellectis, Dr. André Choulika Retires From Calyxt’s Board of Directors

Ads